Unknown

Dataset Information

0

Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production.


ABSTRACT: Reports describing the effect of interferon-gamma (IFNgamma) on interleukin-1beta (IL-1beta) production are conflicting. We resolve this controversy by showing that IFNgamma potentiates IL-1beta release from human cells, but transiently inhibits the production of IL-1beta from mouse cells. Release from this inhibition is dependent on suppressor of cytokine signalling 1. IL-1beta and Th17 cells are pathogenic in mouse models for autoimmune disease, which use Mycobacterium tuberculosis (MTB), in which IFNgamma and IFNbeta are anti-inflammatory. We observed that these cytokines suppress IL-1beta production in response to MTB, resulting in a reduced number of IL-17-producing cells. In human cells, IFNgamma increased IL-1beta production, and this might explain why IFNgamma is detrimental for multiple sclerosis. In mice, IFNgamma decreased IL-1beta and subsequently IL-17, indicating that the adaptive immune response can provide a systemic, but transient, signal to limit inflammation.

SUBMITTER: Masters SL 

PROVIDER: S-EPMC2920446 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production.

Masters Seth L SL   Mielke Lisa A LA   Cornish Ann L AL   Sutton Caroline E CE   O'Donnell Joanne J   Cengia Louise H LH   Roberts Andrew W AW   Wicks Ian P IP   Mills Kingston H G KH   Croker Ben A BA  

EMBO reports 20100702 8


Reports describing the effect of interferon-gamma (IFNgamma) on interleukin-1beta (IL-1beta) production are conflicting. We resolve this controversy by showing that IFNgamma potentiates IL-1beta release from human cells, but transiently inhibits the production of IL-1beta from mouse cells. Release from this inhibition is dependent on suppressor of cytokine signalling 1. IL-1beta and Th17 cells are pathogenic in mouse models for autoimmune disease, which use Mycobacterium tuberculosis (MTB), in w  ...[more]

Similar Datasets

| S-EPMC3143647 | biostudies-literature
| S-EPMC8426678 | biostudies-literature
| S-EPMC3487588 | biostudies-literature
| S-EPMC1221562 | biostudies-other
| S-EPMC64850 | biostudies-literature
| S-EPMC3508843 | biostudies-literature
| S-EPMC4979599 | biostudies-literature
| S-EPMC3365135 | biostudies-literature
| S-EPMC4167721 | biostudies-literature
| S-EPMC5004192 | biostudies-literature